Clinical Trials Search

Titlesort ascending Intervention NCT ID Sponsor Status
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and... Dexamethasone, Fosaprepitant Dimeglumine, Olanzapine, Ondansetron Hydrochloride, Palonosetron Hydrochloride, Placebo NCT03578081 Alliance for Clinical Trials in Oncology Active, not recruiting
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer... Megestrol Acetate, Olanzapine, Questionnaire Administration NCT04939090 Alliance for Clinical Trials in Oncology Recruiting
Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by... Laboratory Biomarker Analysis, Nutritional Intervention, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration NCT03757949 Southwest Oncology Group Recruiting
NR in Chemo-induced Peripheral Neuropathy Nicotinamide Riboside NCT03642990 Donna Hammond, PhD Recruiting
Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III... Nilotinib, Nilotinib Hydrochloride Monohydrate, Paclitaxel, Placebo, Questionnaire Administration NCT04205903 Ohio State University Comprehensive Cancer Center Recruiting
New Assessment System in Measuring Symptom Distress in Cancer Patients Interview, Quality-of-Life Assessment, Questionnaire Administration NCT00505245 M.D. Anderson Cancer Center Recruiting
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Cognitive Assessment, Quality-of-Life Assessment NCT00772200 Children's Oncology Group Recruiting
Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or... Dexamethasone, Laboratory Biomarker Analysis, Netupitant/Palonosetron Hydrochloride, Olanzapine, Placebo, Prochlorperazine, Quality-of-Life Assessment NCT03367572 University of Rochester NCORP Research Base Recruiting
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer Laboratory Biomarker Analysis, Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim, Surgical Procedure NCT02636582 National Cancer Institute (NCI) Active, not recruiting
NCI COVID-19 in Cancer Patients, NCCAPS Study Biospecimen Collection, Data Collection, Quality-of-Life Assessment, Questionnaire Administration NCT04387656 National Cancer Institute (NCI) Active, not recruiting

Pages